UT Transplant Center Faculty
Jose Almeda, MD
Assistant Professor, Hepatobiliary and Pancreatic Surgery, UT Transplant Center
Director, Pediatric Transplant Surgery, CHRISTUS Santa Rosa Children's Hospital
American Board of Surgery
American Society of Transplant Surgeons for Liver and Kidney Transplantation
MD, UT School of Medicine San Antonio, The University of Texas Health Science Center San Antonio, 2002
Organ transplantation and complex hepatobiliary and pancreatic surgery (adults and children), University of Southern California, Children's Hospital Los Angeles
Clinical interests: transplantation; complex pediatric diseases of the liver and pancreas such as tumors and chronic pancreatitis
Matsuoka L, Almeda JL, Mateo R. Pulsatile perfusion of kidney allografts. Curr Opin Organ Transplant. 2009 Aug;14(4):365-9.
Kim J, Huang E, Sher L, Almeda JL. The role of sirolimus in liver transplantation. Current Opinion in Organ Transplantation: December 2007, Volume 12, Issue 6, p 636-640.
2010, San Antonio Magazine 'Best Doctors'
Biosketch: Dr. Almeda was born in Del Rio, Texas and did his medical school and General Surgery residency training in San Antonio at UTHSCSA. He is certified by The American Board of Surgery. Dr. Almeda completed fellowships in Liver and Kidney Transplantation at the University of Southern California (USC) and is accredited by America Society of Transplant Surgeons.
In addition, under the direction of Rick Selby M.D., he completed an intense fellowship in Hepatobiliary and Pancreatic Surgery also at USC. During this training, he focused on tertiary referrals involving complex liver, bile duct, and pancreatic diseases. Using traditional open, and new laparoscopic techniques, Dr. Almeda now offers San Antonio and South Texas specialized surgical services focused on pancreatic cancer, liver tumors, and bile duct diseases including repair of bile duct injuries. Along with Dr's. Washburn and Halff, the team offers vascular reconstruction for those pancreatic tumors previously categorized as inoperable and can help with liver tumors involving complicated resections. The outcomes of these operations parallel or exceed those of tumors that do not involve vascular structures, thus the benefit to the patients is tremendous.